Human Pluripotent Stem Cell-Derived Atrial and Ventricular Cardiomyocytes Develop from Distinct Mesoderm Populations

Area of Science:

• Cardiology
• Stem Cell Biology
• Developmental Biology

Background:

• Directing human pluripotent stem cell (hPSC) differentiation into specific cardiomyocyte subtypes is crucial for in vitro cardiovascular disease modeling and therapy development.
• Understanding the developmental origins of distinct cardiac lineages is essential for precise cell generation.

Purpose of the Study:

• To investigate the developmental pathways of human atrial and ventricular cardiomyocyte lineages from hPSCs.
• To identify key signaling pathways and molecular markers involved in specifying atrial and ventricular fates.

Main Methods:

• Utilized hPSCs for directed differentiation studies.
• Analyzed early developmental stages using markers like CD235a and RALDH2.
• Performed molecular and electrophysiological characterization of differentiated cardiomyocytes.

Main Results:

• Retinoic acid signaling at the mesoderm stage is essential for atrial cardiomyocyte specification.
• Ventricular and atrial cardiomyocytes originate from distinct mesodermal populations.
• Optimal specification of cardiac subtypes depends on inducing the correct mesodermal precursors.

Conclusions:

• Elucidated critical factors for human atrial and ventricular lineage development from hPSCs.
• Demonstrated the role of retinoic acid signaling in atrial specification.
• Enabled the generation of highly enriched, functional cardiomyocyte populations for therapeutic applications.